X-BODY owner Contact Information online
from X-BODY, Inc.
X-BODY
US serial number:85111416
Application filling date:Aug. 19, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Oct. 20, 2014
Publication date:Jul. 19, 2011
Abandoned date:Oct. 20, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceuticals, namely, antibody and protein therapeutics for the treatment of neoplastic disease, cancer, inflammatory disorders, infectious disease, metabolic disease, and genetic disorders
International Class(es): 005- Primary Class
U.S Class(es)
Services:Pharmaceuticals
namely
antibody and protein therapeutics for the treatment of neoplastic disease
cancer
inflammatory disorders
infectious disease
metabolic disease
and genetic disorders
Current owner owner name:X-BODY, Inc.
Current owner owner address:Suite 101
100 Beaver Street
Waltham,
MASSACHUSETTS
UNITED STATES
024538425
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Karen L. Elbing, Ph.D.
Attorney email:tmadministrator@clarkelbing.com
Attorney docket number:50736/T02001
Attorney email authorized:Yes
Correspondent name address:KAREN L. ELBING, PH.D.
CLARK & ELBING LLP
101 FEDERAL ST FL 15
BOSTON,
MASSACHUSETTS
UNITED STATES
02110-1817
Correspondent phone:617.428.0200
Correspondent email:tmadministrator@clarkelbing.com
Correspondent fax:617.428.7045
Correspondent email authorized:Yes
Trademark staff tm attorney:ABRAMS, JACQUELINE WIL
Trademark staff law office assigned X-BODY:LAW OFFICE 101
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (128) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (24) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Jul. 19, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
